| 查看: 134 | 回复: 0 | |||
| 当前主题已经存档。 | |||
[交流]
The naming of Extend-Release Preparations in EU
|
|||
|
Regarding the extended-release preparations, here are definitions of the terms. On the y-axis(vertical) is the amount of active substance absorbed. On the x-axis(horizontal) is time. a: Normal tablet. Immediate action. b: Delayed-release. As you can see the beginning of the absorption is delayed (sometimes by coating the tablet with a gastric resistant layer). This may be because the tablet is supposed to be absorbed from the small intestine and the additional time is needed do it may pass through the stomach(so substances are sensitive to low pH and may be inactivated by gastric acids). c, d, e: Repeat-action preparation. The active substance is placed in layers within a tablet so that it is released in bursts a couple of times depending on the amounts of layers. f: Prolonged release or sustained release. I believe that those two terms are the same. The substance is released more slowly for a longer period of time. As you may notice amount of active substance released decreases with time.(this is a most common type and I believe that is the same as the Chinese sustained-release) g: Those are mixed tablets rarely used and I am not sure how are they called. h: Controlled-release. It is also called therapeutic systems. It is most modern and innovative tablet(laser boring tablet). As you may notice the amount of active substance released is constant in time) Apart from those terms there is still modified-release that I think is the term for all of those except above except a(Normal tablet). Any tablet where the release of the active substance has been changed or modified in any way. Also the term extended release is not very accurate as it can be related to many of the above terms. |
回复此楼» 猜你喜欢
华南理工大学 基础医学学硕和临床医学学硕调剂
已经有11人回复
-
医药研发数据库资源
已经有4人回复
-
药理学论文润色/翻译怎么收费?
已经有172人回复
-
北京协和医学院杰青课题组招聘科研助理
已经有0人回复
-
北京协和医学院杰青课题组招聘科研助理
已经有0人回复
-
求助中国药典1995年版、二部
已经有0人回复
-
北京协和医学院杰青课题组招聘科研助理
已经有0人回复
-
使用MolAICal生成小分子CHARMM力场拓扑和参数文件
已经有0人回复
-
求助https://www.pnas.org/doi/10.1073/pnas.2535777123 全文
已经有0人回复
-
扩散模型生成分子目前痛点，改进方向有哪些，论文创新性卡住了现在
已经有0人回复
-
求解答药物生成模型痛点以及创新点，扩散模型创新
已经有0人回复